NCT05002621View on ClinicalTrials.gov

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

February 13, 2023

Study Completion Date

February 13, 2023

Conditions

Eosinophilic Asthma

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER